US Stock MarketDetailed Quotes

RYTM Rhythm Pharmaceuticals

Watchlist
  • 47.730
  • -1.810-3.65%
Close Oct 31 16:00 ET
  • 47.730
  • 0.0000.00%
Post 16:04 ET
2.92BMarket Cap-10972P/E (TTM)

Rhythm Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Rhythm Pharmaceuticals Q3 2024 Estimates Date

Currency：USDNov 5, 2024

Estimate YoY
Revenue
32.32M
+43.64%
EPS
-0.81
-6.15%
Analyst Rating
Strong Buy

Oct 31, 2024

Rhythm Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 35.739M--
Nov 5, 20242024/Q3-- / 32.324M--
Aug 6, 20242024/Q229.078M / 28.790M--
May 7, 20242024/Q125.967M / 26.896M--
Feb 22, 20242023/Q424.234M / 25.380M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 35.739M--
Nov 5, 20242024/Q3-- / 32.324M--
Aug 6, 20242024/Q229.078M / 28.790M--
May 7, 20242024/Q125.967M / 26.896M--
Feb 22, 20242023/Q424.234M / 25.380M--

Unlock Free Earnings Estimates

Rhythm Pharmaceuticals Earnings Reports

  • Rhythm Pharmaceuticals | 10-Q/A: Quarterly report (Amendment)

    Aug 14 16:34 ET

  • Rhythm Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 6 16:27 ET

  • Rhythm Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 7 16:46 ET

  • Rhythm Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 29 16:22 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Strong Buy

    • Buy

      90.91%

    • Hold

      9.09%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data